TherapeuticsMD (TXMD) Free Cash Flow (2010 - 2026)
TherapeuticsMD (TXMD) posted Free Cash Flow of $944000.0 for Q1 2026, up 151.73% on a QoQ basis from $375000.0 in Q4 2025, and up 35.05% year-over-year from $699000.0 in Q1 2025.
TherapeuticsMD (TXMD) Free Cash Flow (2010 - 2026) Analysis & Trends
TherapeuticsMD's Free Cash Flow history runs 17 years deep, the most recent figure standing at $944000.0 for Q1 2026.
- Quarterly Free Cash Flow rose 35.05% year-over-year to $944000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (up 28.65% YoY) and the FY2025 annual result came in at $2.5 million, up 109.74% from the prior year.
- Free Cash Flow was $944000.0 for Q1 2026 at TherapeuticsMD, up from $375000.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at $22.6 million in Q4 2022 and bottomed at -$20.7 million in Q2 2022.
- A 5-year average of -$1.1 million and a median of $17000.0 in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow slumped 132.14% — and 2025, when it surged 2105.88%.
- TherapeuticsMD's Free Cash Flow stood at $22.6 million in 2022, then slumped by 132.14% to -$7.3 million in 2023, then surged by 100.23% to $17000.0 in 2024, then jumped by 2105.88% to $375000.0 in 2025, then soared by 151.73% to $944000.0 in 2026.
- Business Quant data shows TXMD's Free Cash Flow at $944000.0 in Q1 2026, $375000.0 in Q4 2025, and $999000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | 944,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 944,000.00 |
| Mar 31, 2026 | 944,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Jun 30, 2025 | 381,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Mar 31, 2025 | 699,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | -71,000.00 |
| Sep 30, 2024 | -71,000.00 |
| Jun 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | -229,000.00 |
| Mar 31, 2024 | -229,000.00 |
| Dec 31, 2023 | -7.27 Mn |
| Dec 31, 2023 | -7.27 Mn |